Follow
Aaron (Pang-Yu) Hsueh
Title
Cited by
Cited by
Year
Biodegradation of elastin‐like polypeptide nanoparticles
M Shah, PY Hsueh, G Sun, HY Chang, SM Janib, JA MacKay
Protein science 21 (6), 743-750, 2012
1132012
A quantitative recipe for engineering protein polymer nanoparticles
SM Janib, MF Pastuszka, S Aluri, Z Folchman-Wagner, PY Hsueh, P Shi, ...
Polymer chemistry 5 (5), 1614-1625, 2014
922014
Design and cellular internalization of genetically engineered polypeptide nanoparticles displaying adenovirus knob domain
G Sun, PY Hsueh, SM Janib, S Hamm-Alvarez, JA MacKay
Journal of controlled release 155 (2), 218-226, 2011
712011
A thermo-responsive protein treatment for dry eyes
W Wang, A Jashnani, SR Aluri, JA Gustafson, PY Hsueh, F Yarber, ...
Journal of Controlled Release 199, 156-167, 2015
642015
Imbalanced Rab3D versus Rab27 increases cathepsin S secretion from lacrimal acini in a mouse model of Sjögren's Syndrome
Z Meng, MC Edman, PY Hsueh, CY Chen, W Klinngam, T Tolmachova, ...
American Journal of Physiology-Cell Physiology 310 (11), C942-C954, 2016
302016
Tear-mediated delivery of nanoparticles through transcytosis of the lacrimal gland
PY Hsueh, MC Edman, G Sun, P Shi, S Xu, Y Lin, H Cui, ...
Journal of Controlled Release 208, 2-13, 2015
242015
A multivalent ICAM-1 binding nanoparticle which inhibits ICAM-1 and LFA-1 interaction represents a new tool for the investigation of autoimmune-mediated dry eye
PY Hsueh, Y Ju, A Vega, MC Edman, JA MacKay, SF Hamm-Alvarez
International Journal of Molecular Sciences 21 (8), 2758, 2020
152020
Methods and Therapeutics Comprising Ligand-Targeted ELPs
S Hamm-Alvarez, JA MacKay, G Sun, PY Hsueh
US Patent App. 13/764,476, 2013
132013
METHODS AND THERAPEUTICS COMPRISING LIGAND-TARGETED ELPs
S Hamm-Alvarez, JA MacKay, G Sun, PY Hsueh
US Patent App. 14/811,720, 2016
42016
Icam-1 targeting elps
SF Hamm-Alvarez, JA MacKay, PY Hsueh
US Patent App. 14/684,162, 2015
42015
Icam-1 targeting elps
SF Hamm-Alvarez, JA MacKay, PY Hsueh
US Patent App. 16/125,538, 2019
22019
Use of nucleofection to efficiently transfect primary rabbit lacrimal gland acinar cells
J Contreras, PY Hsueh, H Pei, SF Hamm-Alvarez
Cytotechnology 64, 149-156, 2012
22012
Methods and therapeutics comprising ligand-targeted ELPs
S Hamm-Alvarez, JA MacKay, G Sun, PY Hsueh
US Patent 11,224,662, 2022
2022
Targeting of elastin-like polypeptide nanoparticles to ICAM-1 in lacrimal glands for therapy of SjÖgren's Syndrome
PY Hsueh, SR Janga, JA Mackay, SF Hamm-Alvarez
Investigative Ophthalmology & Visual Science 55 (13), 4634-4634, 2014
2014
Bridging ocular therapeutics and contact lenses via thermo-responsive protein polymers
W Wang, P Shi, S Aluri, PY Hsueh, M Edman, D Ryan, R McKown, ...
Investigative Ophthalmology & Visual Science 54 (15), 2668-2668, 2013
2013
Ocular Drug Delivery Using A Thermo-responsive Lacritin Fusion Protein
JA MacKay, W Wang, B Droese, M Shah, PY Hsueh, G Sun, ...
Investigative Ophthalmology & Visual Science 53 (14), 492-492, 2012
2012
Controlled Ocular Drug Delivery Using Peptide-Mediated Phase Separation
JA MacKay, A Jashnani, PY Hsueh, S Janib, S Hamm-Alvarez
Investigative Ophthalmology & Visual Science 51 (13), 4150-4150, 2010
2010
Ocular delivery of a model biopharmaceutical, lacritin, using protein polymers
JA MacKay, W Wang, P Hsueh, M Edman-Woolcott, SF Hamm-Alvarez
The system can't perform the operation now. Try again later.
Articles 1–18